Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00732199
Other study ID # CDA-2-019-07F
Secondary ID
Status Completed
Phase N/A
First received August 7, 2008
Last updated October 9, 2015
Start date October 2008
Est. completion date April 2015

Study information

Verified date October 2015
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose for our research protocol is to examine the role of breathing control mechanisms that determine the development of sleep-disordered breathing in the elderly. This proposal will focus on key factors that contribute to the control of ventilation in healthy individuals and in subjects with sleep-disordered breathing. We will study the age-specific changes in both normal persons and sleep individuals with sleep apnea.


Description:

Sleep apnea-hypopnea syndrome (SAS) is a relatively common disorder in the US population with significant adverse health consequences. Despite the high prevalence of SAS in elderly individuals, the underlying mechanisms have remained elusive. Specifically, we do not know whether the high prevalence of sleep apnea in older adults is due to increased central breathing instability. This proposal focuses on investigating age-specific differences in the susceptibility to central breathing instability in healthy individuals as well as individuals with sleep apnea.

This project will investigate the following specific objectives:

- Determine age-specific changes in the hypocapnic apneic threshold during sleep in

- elderly vs young individuals without sleep apnea

- elderly vs young individuals with sleep apnea.

- Determine age-specific changes in long-term facilitation during sleep in

- elderly versus young individuals without sleep apnea

- elderly vs young individuals with sleep apnea.

- We will investigate the susceptibility to central breathing instability by mechanically ventilating the subjects during NREM sleep using pressure support ventilation. We will compare the hypocapnic apneic threshold in old (age>60-65 years) and young (age 18-40years) individuals who are healthy as well as in those with sleep-disordered breathing. We will also measure the parameters over a continuum of age from 18 to 89y.

- We will investigate whether there is a difference in the susceptibility to long term facilitation of genioglossus activity and ventilation between young and old healthy individuals in response to episodic hypoxia, while maintaining isocapnia. We will conduct similar experiments in young and old individuals with sleep apnea.

Sleep apnea is very common in older veterans and is associated with significant cardiovascular complications. Greater insight into the pathogenesis will have a positive impact on the health of veterans suffering from this condition. This proposal will further our understanding of the pathogenesis of breathing instability leading to sleep-disordered breathing during sleep. Thus, we anticipate our findings will provide a basis for new approaches to prevention and management of SAS in veterans.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria:

- Normal subjects without sleep apnea (controls) and individuals with sleep apnea.

Exclusion Criteria:

- Pregnancy,

- history of active coronary artery disease-including stable and unstable angina,

- myocardial infarction,

- history of congestive heart failure,

- stroke, who have excessive daytime sleepiness with Epworth Sleepiness Scale of >15 will not be included in the study

- patient with OSA who

- depression,

- schizophrenia,

- untreated hypothyroidism,

- diabetes on insulin,

- seizure disorder,

- intrinsic renal and liver disorders,

- failure to give informed consent,

- patients with evidence of pulmonary diseases based on history and abnormal pulmonary function testing, including obstructive (ratio of predicted forced expiratory volume to forced vital capacity, <80% predicted) or restrictive lung disorders (total lung capacity <80% predicted) with resting oxygen saturation of <96% and kyphoscoliosis (chest wall deformities) will be excluded,

- patients on certain medications including, opiates derivatives, stimulants, antidepressants, tranquilizers, anti-psychotic agents, theophylline and other central nervous system altering medications will be ineligible,

- history of alcohol or recreational drug use will also serve as grounds for exclusion,

- patients with body mass index (BMI) >34kg/m2 will be excluded,

- subjects with sleep apnea are already using continuous positive airway pressure for more than 7 days as therapy will not be eligible.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
hyperventilation and episodic hypoxia
noninvasive hyperventilation to determine apneic threshold; episodic hypoxia to determine long term facilitation

Locations

Country Name City State
United States John D. Dingell VA Medical Center, Detroit, MI Detroit Michigan

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Apneic threshold 4-6 wks for each participant No
Secondary Long-term facilitation 4-6 wks for each participant No
Secondary Upper airway resistance 4-6 wks for each participant No
See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT03919955 - A Novel Pharmacological Therapy for Obstructive Sleep Apnea Phase 2
Completed NCT03927547 - Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Completed NCT02188498 - Electrocardiography Data Analysis in Sleep Disorders
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00747890 - Surgical Treatment of Mild Obstructive Sleep Apnea N/A
Active, not recruiting NCT00738179 - Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease Phase 3
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Completed NCT00202501 - Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome N/A
Completed NCT00047463 - Effects of Treating Obstructive Sleep Apnea in Epilepsy Phase 2
Not yet recruiting NCT06029881 - Portable System for Non-intrusive Monitoring of Sleep
Recruiting NCT06093347 - Central Apnoea Monitor Study
Terminated NCT05445869 - Severe OSA Study (SOS) N/A
Withdrawn NCT04096261 - The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
Recruiting NCT04575740 - Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea N/A
Completed NCT04676191 - Validation of a Contactless Vital Signs Measurement Sensor N/A
Recruiting NCT06015620 - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed NCT06051097 - Metabolic Syndrome and Obstructive Sleep Apnea
Completed NCT05687097 - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury